FIELD: medicine.
SUBSTANCE: invention relates to medicine and relates to a method for detecting MUC-1 proteolysis products having a C-terminal lysine in a liquid, in which the test liquid is brought into contact with the test system to detect MUC-1 proteolysis products having a C-terminal lysine, which includes at least one of the following: a full-length molecule of plasminogen, its fragment having a sequence SEQ ID NO: 1–4, 6–20. System contains labeled monoclonal antibodies to MUC-1 and a solid carrier with one of the attached to it: a full-length plasminogen molecule, its fragment having a sequence SEQ ID NO: 1–4, 6–20, or monoclonal antibodies attached to the carrier to MUC-1 and labeled with one of: a full-length plasminogen molecule, it’s fragment having a sequence SEQ ID NO: 1–4, 6–20. If the threshold level of optical density, determined for a liquid that does not have MUC-1 with C-terminal lysine, is exceeded, the increased content of MUC-1 proteolysis products having a C-terminal lysine is determined in the test liquid.
EFFECT: invention provides detection of a subject having an elevated level of MUC-1 with a C-terminal lysine that is capable to bind to plasminogen or it’s fragments.
5 cl, 2 dwg, 5 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING CONTENT OF PROTEOLYSIS PRODUCTS IN BLOOD PLASMA AND DIAGNOSTIC TEST SYSTEM THEREFOR | 2015 |
|
RU2597782C1 |
METHOD OF DIAGNOSING ONCOLOGICAL DISEASES AND IMMUNOASSAY SET FOR ITS REALISATION | 2012 |
|
RU2522231C1 |
METHOD OF DETERMINING HIGH LEVEL OF AUTOANTIBODIES TO HUMAN PLASMINOGEN AND DEGRADATION PRODUCTS THEREOF AND DIAGNOSTIC TEST SYSTEM THEREFOR | 2014 |
|
RU2597783C2 |
RECOMBINANT POLYPEPTIDE WITH HUMAN PLASMINOGEN PROPERTIES TO CONVERT INTO PLASMIN IF ACTIVATED WHICH CATALYSES FIBRIN SPLITTING, DNA FRAGMENT CODING POLYPEPTIDE, RECOMBINANT PLASMID DNA FOR POLYPEPTIDE EXPRESSION AND TRANSFORMED Escherichia coli CELL - POLYPEPTIDE PRODUCER | 2009 |
|
RU2432397C2 |
RECOMBINANT POLYPEPTIDE WITH HUMAN PLASMINOGEN PROPERTIES TO CONVERT INTO PLASMIN IF ACTIVATED WHICH CATALYSES FIBRIN SPLITTING, DNA FRAGMENT CODING POLYPEPTIDE, RECOMBINANT PLASMID DNA FOR POLYPEPTIDE EXPRESSION AND TRANSFORMED Escherichia coli CELL - POLYPEPTIDE PRODUCER | 2009 |
|
RU2432396C2 |
COMPOSITION, METHOD AND SET FOR PRODUCTION OF PLASMIN | 2009 |
|
RU2497948C2 |
METHOD FOR ANGIOGENESIS INHIBITION WITH RECOMBINANT FORMS OF UROKINASE | 2012 |
|
RU2528249C2 |
VERSIONS OF PLASMINOGEN AND PLASMIN | 2010 |
|
RU2564131C2 |
HUMANIZED ANTIBODIES SPECIFIC TO ALPHA-ENOLASE AND METHODS FOR USE IN ANTITUMOR THERAPY | 2014 |
|
RU2761662C2 |
COMPLEX CONTAINING Fab FRAGMENT OF ANTI-HUMAN MUC1 ANTIBODY, PEPTIDE LINKER AND/OR LIGAND | 2019 |
|
RU2814073C2 |
Authors
Dates
2018-12-27—Published
2016-12-22—Filed